Other substances

Lonafarnib

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
4
 AI-suggested references
0
 Clinical trials

 

Supporting references

Link Tested on Impact factor Notes Publication date
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
CaCo-2 cells 15.58 Aug/11/2020

AI-suggested references

Link Publication date
New pharmaceuticals approved by FDA in 2020: Small-molecule drugs derived from amino acids and related compounds.
Mar/08/2022
Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.
Nov/05/2020
A metabolic modeling approach reveals promising therapeutic targets and antiviral drugs to combat COVID-19.
Jun/07/2021
SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12)
Jul/09/2020
Export (.csv)